ADVFN US – Market Content Editor
-

Tenon Medical shares dip after announcing $2.85 million PIPE financing
Shares of Tenon Medical Inc. (NASDAQ:TNON) slipped 2.5% on Tuesday after the medical device company announced the pricing of a $2.85 million private investment in public equity (PIPE) transaction. Under the terms of the deal, Tenon will issue approximately 2.22 million shares of common stock along with warrants to purchase an equal number of shares.…
-

Blaize Holdings shares sink after announcing $30 million PIPE financing deal
Shares of Blaize Holdings Inc. (NASDAQ:BZAI) dropped 15.1% on Tuesday after the edge artificial intelligence computing company announced a $30 million private investment in public equity (PIPE) agreement with Polar Asset Management Partners. Under the deal, Blaize will issue 9,375,000 shares of common stock at $3.20 per share, alongside warrants to purchase an additional 9,375,000…
-

VSee Health shares surge after securing FedRAMP approval and expanding ICU robotics program
Shares of VSee Health Inc. (NASDAQ:VSEE) jumped 10.7% on Tuesday after the telehealth technology company received FedRAMP Moderate authorization, a key certification that allows it to provide secure telemedicine solutions to U.S. federal agencies. The milestone coincides with the company’s push into robotic-assisted care for intensive care units (ICUs). The approval gives VSee the green…
-

Century Aluminum shares slide after Glencore moves to offload major stake
Shares of Century Aluminum Co. (NASDAQ:CENX) fell 11% on Tuesday after reports surfaced that Glencore Plc plans to sell a substantial portion of its holdings in the U.S.-based aluminum producer through an overnight block trade. According to Bloomberg, Glencore is aiming to raise as much as $284.9 million by selling 9 million Century Aluminum shares.…
-

UBS says three key forces will keep fueling the stock market rally
UBS expects U.S. equities to extend their gains, supported by a combination of Federal Reserve policy easing, strong corporate earnings, and accelerating artificial intelligence (AI) investment, according to a research note published Tuesday. “The Federal Reserve’s policy easing, robust corporate profits, and strong AI spending have been the key market drivers, in our view, and…
-

Bitcoin slides to $104K despite new buying from Strategy and optimism over U.S. government reopening
Bitcoin (COIN:BTCUSD) extended its decline on Tuesday, giving back more of last week’s gains as optimism surrounding progress to end the U.S. government shutdown and renewed corporate buying failed to lift sentiment. The world’s largest cryptocurrency dropped 0.9% to $104,180 by 00:25 ET (05:25 GMT). Bitcoin remains muted despite shutdown progress and fresh Strategy purchases…
-

Metal prices climb broadly as U.S. steel utilization strengthens
Metal prices advanced across the board on Tuesday, with both precious and base metals recording solid gains amid improving sentiment in the industrial sector. Palladium led the rally, jumping 2.11% to $1,447 per ounce, followed by platinum, which rose 1.53% to $1,598 per ounce. Silver gained 1.13% to $51.08 per ounce, while gold added 0.63%,…
-

HealthStream stock edges higher after unveiling $10 million share repurchase program
Shares of HealthStream Inc (NASDAQ:HSTM) climbed 2.2% on Tuesday after the healthcare technology company announced a new stock buyback plan valued at up to $10 million. The company’s Board of Directors authorized the program, which will permit HealthStream to repurchase its common shares through a variety of methods, including open-market transactions, privately negotiated deals, or…
-

LivePerson stock jumps after Citron Research praises strong earnings and AI potential
Shares of LivePerson (NASDAQ:LPSN) soared 35% on Tuesday after Citron Research published a bullish note highlighting the company’s better-than-expected earnings and emerging strength in its AI-driven business model. The customer engagement software provider reported revenue of $60.2 million, topping analyst forecasts of $57.4 million, while also delivering stronger-than-anticipated EBITDA results. Citron attributed part of this…
-

Salarius Pharmaceuticals stock tumbles after announcing $7 million discounted public offering
Shares of Salarius Pharmaceuticals Inc (NASDAQ:SLRX) plunged 45.8% on Tuesday after the clinical-stage biopharmaceutical firm announced a $7 million underwritten public offering priced well below its prior closing level. The offering was priced at $1.50 per share of common stock with accompanying warrants, marking a steep discount. It includes 2,514,335 common shares and pre-funded warrants…